Skip to main content

Table 2 Association between baseline patient characteristics and mortality according to Cox regression analysis, unadjusted and adjusted for potential confounders

From: The impact of warfarin on operative delay and 1-year mortality in elderly patients with hip fracture: a retrospective observational study

 

Unadjusted Cox regression model

Adjusted Cox regression model

Crude HR

CI 95%

p value

Adjusted HR

CI 95%

p value

Age (ref: 65–74 yrs)

 75–84 yrs

1.13

0.69–1.84

0.633

0.88

0.53–1.45

0.621

 85–94 yrs

2.27

1.43–3.61

0.001

1.48

0.92–2.39

0.107

 ≥ 95 yrs

4.33

2.47–7.57

< 0.001

2.96

1.65–5.31

< 0.001

Gender (ref: male)

 Female

0.63

0.50–0.80

< 0.001

0.71

0.55–0.90

0.005

Therapy (ref: control group)

 Warfarin

2.15

1.59–2.92

< 0.001

1.42

1.03–1.95

0.034

 Antiplatelet

1.23

0.96–1.58

0.10

0.95

0.73–1.23

0.687

ASA score (ref: 1/2)

 3

3.27

1.20–8.91

0.021

1.72

0.62–4.79

0.300

 4/5

7.79

2.90–20.96

< 0.001

2.46

0.87–6.92

0.089

CCI

1.32

1.26–1.39

< 0.001

1.24

1.17–1.32

< 0.001

Time to surgery (ref: < 48 h)

 > 48 h

1.24

0.99–1.56

0.066

1.53

1.04–2.25

0.032

Blood loss (ref: 0–490 ml)

 491–980 ml

1.92

1.38–2.66

< 0.001

1.60

1.14–2.23

0.006

 981–1470 ml

1.97

1.36–2.88

< 0.001

1.38

0.94–2.04

0.097

 > 147 ml

2.60

1.88–3.59

< 0.001

1.81

1.30–2.53

< 0.001

AO/OTA Classification (ref: lateral fracture—A)

 Medial fracture—B

0.89

0.71–1.12

0.332

   

Types of surgical Procedure (ref: fixation)

 Reconstruction

0.93

0.74–1.17

0.515